NCT02417688

Brief Summary

To demonstrate feasibility of imaging Cu\[64\]-25%-CANF-Comb uptake in the atherosclerosis of the carotid artery of patients for whom carotid artery endarterectomy surgery is planned in comparison to the carotid artery for which intervention is not planned.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P50-P75 for phase_1

Timeline
Completed

Started Apr 2015

Longer than P75 for phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 5, 2015

Completed
6 days until next milestone

First Submitted

Initial submission to the registry

April 11, 2015

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 16, 2015

Completed
6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2021

Completed
Last Updated

October 17, 2022

Status Verified

October 1, 2022

Enrollment Period

6.1 years

First QC Date

April 11, 2015

Last Update Submit

October 13, 2022

Conditions

Keywords

carotid atherosclerosis, PET imaging agent

Outcome Measures

Primary Outcomes (1)

  • PET SUV (Standardized Uptake Value)

    Difference in SUV between the carotid with atherosclerosis (carotid artery to be undergo surgery) and the carotid artery without significant disease (artery for which surgery is not planned).

    22-26 hours

Study Arms (1)

Cu[64]-25%-CANF-Comb PET-MR

EXPERIMENTAL

Single IV injection of 4-8 mCi of Cu\[64\]-25%-CANF-Comb with a mass no more than 100 μgrams followed by PET-MR Imaging

Device: Cu[64]-25%-CANF-Comb PET-MR

Interventions

Single IV injection of a novel radiopharmaceutical for diagnostic imaging of atherosclerosis by PET-MR

Also known as: Cu[64]-25%-CANF-Comb
Cu[64]-25%-CANF-Comb PET-MR

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients with carotid atherosclerosis
  • Patients must be scheduled for carotid intervention (endarterectomy surgery)
  • Signed informed consent.

You may not qualify if:

  • Unstable clinical conditions
  • Pregnancy and lactation
  • Inability to lie still for up to 60 min with arms down at sides for PET-MR imaging
  • Unwilling to comply with study procedures and unavailable for the duration of the study.
  • Pacemakers, brain aneurysm clip, shrapnel and other typical contraindications for MRI imaging.
  • Inability to provide written informed consent.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Washington University in St.Louis

St Louis, Missouri, 63110, United States

Location

Related Publications (2)

  • Liu Y, Pressly ED, Abendschein DR, Hawker CJ, Woodard GE, Woodard PK, Welch MJ. Targeting angiogenesis using a C-type atrial natriuretic factor-conjugated nanoprobe and PET. J Nucl Med. 2011 Dec;52(12):1956-63. doi: 10.2967/jnumed.111.089581. Epub 2011 Nov 2.

    PMID: 22049461BACKGROUND
  • Liu Y, Abendschein D, Woodard GE, Rossin R, McCommis K, Zheng J, Welch MJ, Woodard PK. Molecular imaging of atherosclerotic plaque with (64)Cu-labeled natriuretic peptide and PET. J Nucl Med. 2010 Jan;51(1):85-91. doi: 10.2967/jnumed.109.066977. Epub 2009 Dec 15.

    PMID: 20008978BACKGROUND

MeSH Terms

Conditions

Carotid Artery Diseases

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Pamela K Wooderd, MD

    Washington University School of Medicine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 11, 2015

First Posted

April 16, 2015

Study Start

April 5, 2015

Primary Completion

April 30, 2021

Study Completion

April 30, 2021

Last Updated

October 17, 2022

Record last verified: 2022-10

Data Sharing

IPD Sharing
Will share

The investigators may share your images with other researchers. They may be doing research in areas similar to this research or in other unrelated areas. These researchers may be at Washington University, at other research centers and institutions, or industry sponsors of research. The investigators may also share your research data with large data repositories (a repository is a database of information) for broad sharing with the research community. If the individual research data is placed in one of these repositories only qualified researchers, who have received prior approval from individuals that monitor the use of the data, will be able to look at the information.

Shared Documents
STUDY PROTOCOL, ICF, CSR
Time Frame
Beginning 3 months and ending 10 years following article publication.
Access Criteria
Proposals should be directly submitted to pwoodard@wustl.edu.

Locations